help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nalesnik, M. A.
Right arrow Articles by Locker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nalesnik, M. A.
Right arrow Articles by Locker, J.

American Journal of Pathology, Vol 133, 173-192, Copyright © 1988 by American Society for Investigative Pathology

REGULAR ARTICLES

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression

MA Nalesnik, R Jaffe, TE Starzl, AJ Demetris, K Porter, JA Burnham, L Makowka, M Ho and J Locker
Department of Pathology, Veteran's Administration Hospital, Pittsburgh, Pennsylvania.

Posttransplant lymphoproliferative disorders (PTLDs) were diagnosed in 43 patients from the Pittsburgh-Denver series between June 1980 and March 1987. This constitutes a detection rate of 1.7%. Major categories of clinical presentation included a mononucleosislike syndrome, gastrointestinal/abdominal disease, and solid organ disease. The median time of onset in patients initially immunosuppressed with cyclosporine- A (CsA)-containing regimens was 4.4 months after transplant, regardless of tumor clonality. A strong association of PTLD with Epstein-Barr virus (EBV) was observed. A histologic spectrum of lesions from polymorphic to monomorphic was observed. Whereas polymorphic lesions could be either clonal or nonclonal, monomorphic lesions appeared to be clonal in composition. The presence of large atypical cells (atypical immunoblasts) or necrosis did not appreciably worsen the prognosis. Twelve patients had clonal, 13 had nonclonal, and five had both clonal and nonclonal tumors. Clonality was indeterminate in 13 cases. Most patients were treated with a regimen based on reduced immunosuppression and supportive surgery. Almost all nonclonal and about half of the clonal lesions respond to this conservative therapy, indicating that it is an appropriate first line of treatment. This behavior suggests that a spectrum of lesions ranging from infectious mononucleosis to malignant lymphoma constitutes the entity known as PTLD. Some monoclonal tumors can undergo regression, however, apparently in response to host immune control mechanisms. Because of its short latency and strong association with EBV, PTLD is an important model for the study of virus-associated tumor progression in humans.


This article has been cited by other articles:


Home page
 NEJMHome page
J. A. Fishman
Infection in Solid-Organ Transplant Recipients
N. Engl. J. Med., December 20, 2007; 357(25): 2601 - 2614.
[Full Text] [PDF]

Home page
 haematolHome page
E. Gonzalez-Barca, E. Domingo-Domenech, F. J. Capote, J. Gomez-Codina, A. Salar, A. Bailen, J.-M. Ribera, A. Lopez, J. Briones, A. Munoz, et al.
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease
Haematologica, November 1, 2007; 92(11): 1489 - 1494.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. J Everly, R. D Bloom, D. E Tsai, and J. Trofe
Posttransplant Lymphoproliferative Disorder
Ann. Pharmacother., November 1, 2007; 41(11): 1850 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
M S Dhillon, J K Rai, B K Gunson, S Olliff, and J Olliff
Post-transplant lymphoproliferative disease in liver transplantation
Br. J. Radiol., May 1, 2007; 80(953): 337 - 346.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. R. Mikuls, J. O. Endo, S. E. Puumala, P. A. Aoun, N. A. Black, J. R. O'Dell, J. A. Stoner, E. C. Boilesen, M. A. Bast, D. A. Bergman, et al.
Prospective Study of Survival Outcomes in Non-Hodgkin's Lymphoma Patients With Rheumatoid Arthritis
J. Clin. Oncol., April 1, 2006; 24(10): 1597 - 1602.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. M. Ghobrial, T. M. Habermann, M. J. Maurer, S. M. Geyer, K. M. Ristow, T. S. Larson, R. C. Walker, S. M. Ansell, W. R. Macon, G. G. Gores, et al.
Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative Disorders
J. Clin. Oncol., October 20, 2005; 23(30): 7574 - 7582.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. S. Zaltzman, R. Prasad, K. Chun, and S. Jothy
Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus
Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1748 - 1751.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
E. Schauer, S. Webber, M. Green, and D. Rowe
Surface Immunoglobulin-Deficient Epstein-Barr Virus-Infected B Cells in the Peripheral Blood of Pediatric Solid-Organ Transplant Recipients
J. Clin. Microbiol., December 1, 2004; 42(12): 5802 - 5810.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Gupta, B. K. Shenton, M. A. Gok, C. Wilson, J. Asher, G. Hide, B. Wilkins, and D. Talbot
Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3186 - 3189.
[Full Text] [PDF]

Home page
 Arch DermatolHome page
D. P. Beynet, S. A. Wee, S. S. Horwitz, S. Kohler, S. Horning, R. Hoppe, and Y. H. Kim
Clinical and Pathological Features of Posttransplantation Lymphoproliferative Disorders Presenting With Skin Involvement in 4 Patients
Arch Dermatol, September 1, 2004; 140(9): 1140 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Duval, M. Raphael, C. Brennetot, H. Poirel, O. Buhard, A. Aubry, A. Martin, A. Krimi, V. Leblond, J. Gabarre, et al.
The mutator pathway is a feature of immunodeficiency-related lymphomas
PNAS, April 6, 2004; 101(14): 5002 - 5007.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Lee, O. A. Minai, A. C. Mehta, M. M. DeCamp, and S. Murthy
Pulmonary Nodules in Lung Transplant Recipients: Etiology and Outcome
Chest, January 1, 2004; 125(1): 165 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. J. Siegel, E. Y. Lee, S. C. Sweet, and C. Hildebolt
CT of Posttransplantation Lymphoproliferative Disorder in Pediatric Recipients of Lung Allograft
Am. J. Roentgenol., October 1, 2003; 181(4): 1125 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
W D Bates, D W R Gray, M A Dada, R Chetty, K C Gatter, D R Davies, and P J Morris
Lymphoproliferative disorders in Oxford renal transplant recipients
J. Clin. Pathol., June 1, 2003; 56(6): 439 - 446.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Khanolkar, Z. Fu, L. J. Underwood, K. L. Bondurant, R. Rochford, and M. J. Cannon
CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells
J. Immunol., March 15, 2003; 170(6): 3187 - 3194.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
F. J. Jenkins, D. T. Rowe, and C. R. Rinaldo Jr.
Herpesvirus Infections in Organ Transplant Recipients
Clin. Vaccine Immunol., January 1, 2003; 10(1): 1 - 7.
[Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
V Costes-Martineau, C Delfour, S Obled, L Lamant, G-P Pageaux, P Baldet, P Blanc, and G Delsol
Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review
J. Clin. Pathol., November 1, 2002; 55(11): 868 - 871.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Cadranel, M. Wislez, and M. Antoine
Primary pulmonary lymphoma
Eur. Respir. J., September 1, 2002; 20(3): 750 - 762.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
B. C. Gartner, H. Schafer, K. Marggraff, G. Eisele, M. Schafer, K. Roemer, H.-J. Laws, M. Sester, U. Sester, H. Einsele, et al.
Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease
J. Clin. Microbiol., February 1, 2002; 40(2): 351 - 358.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
Y Sadahira, K Kumori, Y Mikami, T Otsuki, T Manabe, and K Aoyama
Post-transplant malignant lymphoma with monoclonal immunoglobulin gene rearrangement and polyclonal Epstein-Barr virus episomes
J. Clin. Pathol., November 1, 2001; 54(11): 887 - 889.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
T. Cook, R. J. Grostern, N. P. Barney, M. D. Mills, R. Judd, and D. M. Albert
Posttransplantation Lymphoproliferative Disorder Initially Seen as Iris Mass and Uveitis
Arch Ophthalmol, May 1, 2001; 119(5): 768 - 770.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Haddad, S. Paczesny, V. Leblond, J.-M. Seigneurin, M. Stern, A. Achkar, M. Bauwens, V. Delwail, D. Debray, C. Duvoux, et al.
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial
Blood, March 15, 2001; 97(6): 1590 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. J. C. Stevens, E. A. M. Verschuuren, I. Pronk, W. van der Bij, M. C. Harmsen, T. H. The, C. J. L. M. Meijer, A. J. C. van den Brule, and J. M. Middeldorp
Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
Blood, March 1, 2001; 97(5): 1165 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. Leblond, N. Dhedin, M.-F. M. Bruneel, S. Choquet, O. Hermine, R. Porcher, S. N. Quoc, F. Davi, F. Charlotte, R. Dorent, et al.
Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders
J. Clin. Oncol., February 1, 2001; 19(3): 772 - 778.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. S. Cho, G. N. Holland, B. J. Glasgow, S. J. Isenberg, B. L. George, and S. V. McDiarmid
Ocular Involvement in Patients With Posttransplant Lymphoproliferative Disorder
Arch Ophthalmol, February 1, 2001; 119(2): 183 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
P F Demols, P M Cochaux, T Velu, and L Caspers-Velu
Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus
Br. J. Ophthalmol., January 1, 2001; 85(1): 93 - 95.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
L. J. Swinnen
Post-transplant Lymphoproliferative Disorders: Implications for Acquired Immunodeficiency Syndrome-Associated Malignancies
J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 38 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
T. G. Phan, B. P. O'Neill, and P. J. Kurtin
Posttransplant primary CNS lymphoma
Neuro-oncol, October 1, 2000; 2(4): 229 - 238.
[Abstract] [PDF]

Home page
 RadiologyHome page
P. J. Pickhardt, M. J. Siegel, R. J. Hayashi, and M. Kelly
Posttransplantation Lymphoproliferative Disorder in Children: Clinical, Histopathologic, and Imaging Features
Radiology, October 1, 2000; 217(1): 16 - 25.
[Abstract] [Full Text]

Home page
 RadiologyHome page
L. A. Loevner, R. L. Karpati, P. Kumar, D. M. Yousem, W. Hsu, and K. T. Montone
Posttransplantation Lymphoproliferative Disorder of the Head and Neck: Imaging Features in Seven Adults
Radiology, August 1, 2000; 216(2): 363 - 369.
[Abstract] [Full Text]

Home page
 BloodHome page
M. Quaia, P. Zancai, R. Cariati, S. Rizzo, M. Boiocchi, and R. Dolcetti
Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein-Barr virus-immortalized B lymphocytes
Blood, July 15, 2000; 96(2): 711 - 718.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. McKean-Cowdin, H. S. Feigelson, R. K. Ross, M. C. Pike, and B. E. Henderson
Declining Cancer Rates in the 1990s
J. Clin. Oncol., June 11, 2000; 18(11): 2258 - 2268.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. Gallagher, J. T. C. Kwan, and P. A. Andrews
Post-transplantation lymphoproliferative disorder: an unusual presentation in a patient receiving tacrolimus
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 928 - 930.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Martin, F. Baran-Marzak, S. El Mansouri, C. Legendre, V. Leblond, F. Charlotte, F. Davi, D. Canioni, and M. Raphael
Expression of p16/INK4a in Posttransplantation Lymphoproliferative Disorders
Am. J. Pathol., May 1, 2000; 156(5): 1573 - 1579.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
F. Baldanti, P. Grossi, M. Furione, L. Simoncini, A. Sarasini, P. Comoli, R. Maccario, R. Fiocchi, and G. Gerna
High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders
J. Clin. Microbiol., February 1, 2000; 38(2): 613 - 619.
[Abstract] [Full Text]

Home page
 BloodHome page
A. Gustafsson, V. Levitsky, J.-Z. Zou, T. Frisan, T. Dalianis, P. Ljungman, O. Ringden, J. Winiarski, I. Ernberg, and M. G. Masucci
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells
Blood, February 1, 2000; 95(3): 807 - 814.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
T. Greiner, J. O. Armitage, and T. G. Gross
Atypical Lymphoproliferative Diseases
Hematology, January 1, 2000; 2000(1): 133 - 146.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. M. Levine, L. Angel, A. Anzueto, I. Susanto, J. I. Peters, E. Y. Sako, and C. L. Bryan
A Low Incidence of Posttransplant Lymphoproliferative Disorder in 109 Lung Transplant Recipients
Chest, November 1, 1999; 116(5): 1273 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. J. Pickhardt and M. J. Siegel
Posttransplantation Lymphoproliferative Disorder of the Abdomen: CT Evaluation in 51 Patients
Radiology, October 1, 1999; 213(1): 73 - 78.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
J. Setsuda, J. Teruya-Feldstein, N. L. Harris, J. A. Ferry, L. Sorbara, G. Gupta, E. S. Jaffe, and G. Tosato
Interleukin-18, Interferon-{gamma}, IP-10, and Mig Expression in Epstein-Barr Virus-Induced Infectious Mononucleosis and Posttransplant Lymphoproliferative Disease
Am. J. Pathol., July 1, 1999; 155(1): 257 - 265.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. P. Limaye, M.-L. Huang, E. E. Atienza, J. M. Ferrenberg, and L. Corey
Detection of Epstein-Barr Virus DNA in Sera from Transplant Recipients with Lymphoproliferative Disorders
J. Clin. Microbiol., April 1, 1999; 37(4): 1113 - 1116.
[Abstract] [Full Text]

Home page
 BloodHome page
K. G. Lucas, R. Filo, D. K. Heilman, C. H. Lee, and D. J. Emanuel
Semiquantitative Epstein-Barr Virus Polymerase Chain Reaction Analysis of Peripheral Blood From Organ Transplant Patients and Risk for the Development of Lymphoproliferative Disease
Blood, November 15, 1998; 92(10): 3977 - 3979.
[Full Text] [PDF]

Home page
 BloodHome page
M. Benkerrou, J.-P. Jais, V. Leblond, A. Durandy, L. Sutton, P. Bordigoni, J. L. Garnier, J. Le Bidois, F. Le Deist, S. Blanche, et al.
Anti-B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome
Blood, November 1, 1998; 92(9): 3137 - 3147.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Cesarman, A. Chadburn, Y.-F. Liu, A. Migliazza, R. Dalla-Favera, and D. M. Knowles
BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome
Blood, October 1, 1998; 92(7): 2294 - 2302.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. G. Murray, C. M. Constandinou, J. Crocker, L. S. Young, and R. F. Ambinder
Analysis of Major Histocompatibility Complex Class I, TAP Expression, and LMP2 Epitope Sequence in Epstein-Barr Virus-Positive Hodgkin's Disease
Blood, October 1, 1998; 92(7): 2477 - 2483.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Hale, H. Waldmann, and CAMPATH Users
Risks of Developing Epstein-Barr Virus-Related Lymphoproliferative Disorders After T-Cell-Depleted Marrow Transplants
Blood, April 15, 1998; 91(8): 3079 - 3083.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. J. Ying, P. D. Myerowitz, and W. L. Marsh Jr
Posttransplantation Lymphoproliferative Disorder in Cardiac Transplant Allografts
Ann. Thorac. Surg., December 1, 1997; 64(6): 1822 - 1824.
[Abstract] [Full Text]

Home page
 NEJMHome page
K. B. Miller and F. M. Graeme-Cook
Case 19-1996- Multisystem failure in a 33-year-old man after bone marrow transplantation
N. Engl. J. Med., June 20, 1996; 334(25): 1655 - 1662.
[Full Text] [PDF]

Home page
 NEJMHome page
G. Remuzzi and E. Gotti
The Girl with the Curl
N. Engl. J. Med., October 5, 1995; 333(14): 928 - 931.
[Full Text] [PDF]

Home page
 NEJMHome page
E. S. Lee, J. Locker, M. Nalesnik, J. Reyes, R. Jaffe, M. Alashari, B. Nour, A. Tzakis, and P. S. Dickman
The Association of Epstein-Barr Virus with Smooth-Muscle Tumors Occurring after Organ Transplantation
N. Engl. J. Med., January 5, 1995; 332(1): 19 - 25.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
J. H. Ritter and M. R. Wick
Posttransplant Lymphoproliferative Disorders: Immunohistologic Differential Diagnosis With Severe Allograft Rejection
International Journal of Surgical Pathology, October 1, 1994; 2(2): 105 - 115.
[Abstract] [PDF]

Home page
 NEJMHome page
E. B. Papadopoulos, M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M. H. Carabasi, H. Castro-Malaspina, B. H. Childs, A. P. Gillio, T. N. Small, et al.
Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
N. Engl. J. Med., April 28, 1994; 330(17): 1185 - 1191.
[Abstract] [Full Text]

Home page
 NEJMHome page
I. J. Spiro, D. W. Yandell, C. Li, S. Saini, J. Ferry, J. Powelson, W. N. Katkov, and A. B. Cosimi
Lymphoma of Donor Origin Occurring in the Porta Hepatis of a Transplanted Liver
N. Engl. J. Med., July 1, 1993; 329(1): 27 - 29.
[Full Text]

Home page
 NEJMHome page
O. W. Kamel, M. van de Rijn, L. M. Weiss, G. J. Del Zoppo, P. K. Hench, B. A. Robbins, P. G. Montgomery, R. A. Warnke, and R. F. Dorfman
Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and Dermatomyositis
N. Engl. J. Med., May 6, 1993; 328(18): 1317 - 1321.
[Full Text]

Home page
 RadiologyHome page
G. Y. Lim, B. Newman, G. Kurland, and S. A. Webber
Posttransplantation Lymphoproliferative Disorder: Manifestations in Pediatric Thoracic Organ Recipients
Radiology, March 1, 2002; 222(3): 699 - 708.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.